Skip to main content

Peer Review reports

From: A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns

Original Submission
2 May 2021 Submitted Original manuscript
1 Jun 2021 Reviewed Reviewer Report - Sudhakar N
17 Jun 2021 Reviewed Reviewer Report
17 Jul 2021 Author responded Author comments - Valerie Fore DONKENG DONFACK
Resubmission - Version 2
17 Jul 2021 Submitted Manuscript version 2
10 Oct 2021 Reviewed Reviewer Report
5 Nov 2021 Reviewed Reviewer Report
23 Dec 2021 Author responded Author comments - Valerie Fore DONKENG DONFACK
Resubmission - Version 3
23 Dec 2021 Submitted Manuscript version 3
3 Feb 2022 Author responded Author comments - Valerie Fore DONKENG DONFACK
Resubmission - Version 4
3 Feb 2022 Submitted Manuscript version 4
14 Feb 2022 Author responded Author comments - Valerie Fore DONKENG DONFACK
Resubmission - Version 5
14 Feb 2022 Submitted Manuscript version 5
Publishing
15 Feb 2022 Editorially accepted
4 Mar 2022 Article published 10.1186/s12879-022-07157-0

You can find further information about peer review here.

Back to article page